Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present invention relates to an HGF preparation comprising HGF and purified sucrose. The HGF preparation is characterized by being stable even after a long-term storage.
Core Innovation
The disclosure provides an HGF preparation in which addition of purified sucrose suppresses HGF aggregation and improves long-term stability. The preparation is described as reducing HGF aggregate content during storage, and the composition is preferably freeze-dried.
The composition may further include neutral amino acids such as alanine, buffers such as citric acid/citrate salts, sodium chloride, and surfactants such as Polysorbate. The disclosure also describes sucrose content in aqueous and freeze-dried forms.
Examples compare freeze-dried formulations containing sucrose with or without alanine against alanine-only and sucrose-free controls. The examples show reduced HGF aggregate content after storage and improved molecular-weight distribution as assessed by DLS, along with comparisons of HPLC aggregates content.
Claims Coverage
The provided content explicitly identifies one independent claim and includes six main inventive components in a freeze-dried composition format.
Freeze-dried HGF composition with sucrose and excipients
A composition comprising Hepatocyte Growth Factor (HGF), sucrose, alanine, sodium chloride, a citric acid salt, and a Polysorbate, wherein the composition is freeze-dried.
Coverage centers on a freeze-dried HGF composition formulated with sucrose plus alanine, sodium chloride, a citric acid salt, and a Polysorbate.
Stated Advantages
Suppresses HGF aggregation.
Improves long-term stability.
Reduces HGF aggregate content after storage.
Improves molecular-weight distribution.
Documented Applications
Reconstitution of the freeze-dried composition into an injectable solution.
Interested in licensing this patent?